Toshima Parris, Associate Professor of oncology at the Institute of Clinical Sciences, receives SEK 500’000 in research scholarship from the Knut & Ragnvi Jacobsson Family Foundation for a project on triple-negative breast cancer, which is an aggressive and difficult-to-treat form of the disease. The group has recently shown that triple-negative breast cancer contains a large proportion of cancer stem cells, and will now try to develop treatments that kill these cells. Blood and tissue samples (tumor and normal samples) are collected from patients with this type of breast cancer, and then examined using molecular techniques. The researchers want to understand why cancer stem cells are resistant to certain treatments and which drugs can work.